Kura Oncology KURA Commercialization Services — Contract With Customer Liability Current
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's commercialization services — contract with customer liability current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Kura Oncology's commercialization services — contract with customer liability current?
- Kura Oncology (KURA) reported commercialization services — contract with customer liability current of $2M in Q1 2026.
- What does commercialization services — contract with customer liability current mean?
- Reflects the portion of deferred revenue from commercialization services that is expected to be recognized as revenue within the next twelve months. This liability arises when the company receives consideration from a customer before the associated performance obligations are satisfied. It serves as a measure of short-term service delivery commitments.